SpiroChem
SpiroChem, founded in 2011 and headquartered in Basel, Switzerland, is a pioneering research partner dedicated to advancing drug discovery and process R&D chemistry. With additional R&D facilities in Montreal, Canada, the company is strategically positioned close to key life science hubs. SpiroChem’s world-class team combines deep collective expertise with advanced technology platforms, working as an extension of its clients’ teams to accelerate research, regulatory milestones, and innovation.
The portfolio of services distributed includes a comprehensive range of medicinal chemistry solutions: computer-aided drug design, hit validation, hit-to-lead, lead optimization, hit/fragment expansion, properties optimization, SAR elucidation, bioisosteric replacement strategies, IP evaluation, and patent filing. These offerings support the full spectrum of discovery work, from early concept through advanced process development. With an exceptionally high success rate recognized by both industry and academic partners, SpiroChem is consistently validated as a best-in-class provider in modern chemistry research.
